PMID: 11918539Mar 29, 2002Paper

Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations

British Journal of Haematology
Athanasios B T FassasGuido Tricot

Abstract

Involvement of the central nervous system (CNS) by multiple myeloma, as defined by the detection of malignant plasma cells in the cerebrospinal fluid in the presence of suggestive symptoms, is considered extremely rare. We report on the characteristics of 18 such patients diagnosed and treated at the University of Arkansas over the last 10 years for an overall incidence of approximately 1%. Their evaluation revealed association of CNS involvement with unfavourable cytogenetic abnormalities (especially translocations and deletion of the chromosome 13), high tumour mass, plasmablastic morphology, additional extramedullary myeloma manifestations and circulating plasma cells. The presence of these features should alert clinicians to the possibility of CNS involvement. The outcome of these patients was extremely poor despite the use of aggressive local and systemic treatment including autologous stem cell transplants. Given this universally poor prognosis, the application of allogeneic transplants should be studied in this clinical setting.

Citations

Oct 6, 2006·European Radiology·Heike E Daldrup-LinkThomas M Link
Sep 28, 2012·Journal of Neurology·Georgia KaiafaVasilios Perifanis
Mar 14, 2012·Bone Marrow Transplantation·B WirkJ S Moreb
Mar 19, 2008·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Sonia N YeungValerie A White
Dec 20, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Feb 18, 2010·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Oct 3, 2012·Neuropathology : Official Journal of the Japanese Society of Neuropathology·William WuSherif A Rezk
May 25, 2007·Neuro-oncology·Aurelia WavreNicolas Ketterer
Mar 9, 2010·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Tomas PikaVlastimil Scudla
Mar 3, 2004·Radiology·Edgardo J C AngtuacoBart Barlogie
Aug 14, 2012·Leukemia & Lymphoma·Alberto MussettiVittorio Montefusco
Jun 20, 2007·Leukemia & Lymphoma·Nishitha ReddySwami Padmanabhan
Jul 16, 2011·American Journal of Clinical Pathology·Robert B LorsbachFalko Fend
May 22, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·R VelascoJ Bruna
Jan 8, 2005·Clinical Lymphoma·Jan Drappatz, Tracy Batchelor
Sep 30, 2005·European Journal of Haematology·Evangelos TerposJane F Apperley
Oct 20, 2004·British Journal of Haematology·Hong ChangA Keith Stewart
Jul 1, 2009·Brain Pathology·T KuhlmannW Brück
Oct 27, 2007·European Journal of Haematology·Laurens Nieuwenhuizen, Douwe H Biesma
Mar 8, 2006·European Journal of Haematology·Hattori YutakaIkeda Yasuo
Dec 7, 2011·Hematological Oncology·Shane A GangatharanSimon J Harrison
Nov 20, 2013·British Journal of Haematology·Won Jin ChangKihyun Kim
May 22, 2016·Revista brasileira de hematologia e hemoterapia·Thais Rodrigues da Cunha FischerVania Tietsche de Moraes Hungria
Jul 20, 2005·Best Practice & Research. Clinical Haematology·Angela Dispenzieri, Robert A Kyle
Apr 8, 2015·Clinical Lymphoma, Myeloma & Leukemia·Thomas U MarronAjai Chari
Oct 8, 2014·Muscle & Nerve·Divisha RahejaZachary Simmons
Aug 22, 2015·AJR. American Journal of Roentgenology·Abhishek R KeraliyaJyothi P Jagannathan
May 10, 2015·Clinical Radiology·A LasockiS J Harrison
Jan 1, 2014·Clinical Lymphoma, Myeloma & Leukemia·Al-ola AbdallahSaad Z Usmani
Jun 13, 2015·Case Reports in Hematology·Christian W Eskelund, Niels Frost Andersen
Apr 23, 2016·Cancer Biology & Therapy·Muhammad Bilal AbidWee Joo Chng
Jul 28, 2016·American Journal of Clinical Pathology·Adam C Wilberger, Richard A Prayson
Aug 5, 2016·Cytopathology : Official Journal of the British Society for Clinical Cytology·A C W LopesM M Sales

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.